SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study

NCT00511797 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

249

Enrollment

INDUSTRY

Sponsor class

Conditions

Dysmenorrhea

Interventions

DRUG: SH T04740B
DRUG: SH T00186DF
DRUG: SH T04740F
DRUG: Placebo

Sponsor

Bayer